Belvedere Trading
AGL icon

Belvedere Trading’s Agilon Health AGL Stock Holding History

Belvedere Trading’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
+308,700
New +$20.2M ﹤0.01% 169
2024
Q4 		– Sell
-372
Closed -$36.5K – 832
2024
Q3 		$36.5K Buy
+372
New +$48K ﹤0.01% 555

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Belvedere Trading's AGL Position: Q2 2026 in Review

Belvedere Trading opened a new position in Agilon Health (AGL) in Q2 2026: 15,023 shares worth $1.61M. The stake represents ﹤0.01% of the portfolio and ranks #155 among its holdings. This is a return to the name: Belvedere Trading previously reported a position in AGL as recently as Q3 2024.

Belvedere Trading first reported a position in AGL in Q3 2024 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Belvedere Trading held 15,023 shares of Agilon Health worth $1.61M as of Q2 2026.
  • Agilon Health was a new Belvedere Trading position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Belvedere Trading's portfolio in Q2 2026, its #155 holding.
  • Belvedere Trading first reported a position in Agilon Health in Q3 2024 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.